Millennium Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.29M | Sell |
57,031
-65,575
| -53% | -$1.46M | ﹤0.01% | 4196 |
|
|
2025
Q4 | $3.17M | Buy |
122,606
+51,848
| +73% | +$1.23M | ﹤0.01% | 3492 |
|
|
2025
Q3 | $1.82M | Sell |
70,758
-444,266
| -86% | -$10.9M | ﹤0.01% | 4141 |
|
|
2025
Q2 | $12.3M | Buy |
515,024
+169,399
| +49% | +$4.27M | 0.01% | 2046 |
|
|
2025
Q1 | $8.59M | Sell |
345,625
-1,139,887
| -77% | -$27.3M | ﹤0.01% | 2343 |
|
|
2024
Q4 | $28M | Buy |
1,485,512
+879,473
| +145% | +$15.4M | 0.01% | 1239 |
|
|
2024
Q3 | $9.12M | Buy |
+606,039
| New | +$10.4M | ﹤0.01% | 2260 |
|
|
2024
Q2 | – | Sell |
-37,448
| Closed | -$1.07M | – | 6366 |
|
|
2024
Q1 | $1.09M | Buy |
+37,448
| New | +$1.15M | ﹤0.01% | 4216 |
|
|
2023
Q4 | – | Sell |
-49,921
| Closed | -$1.53M | – | 6413 |
|
|
2023
Q3 | $1.53M | Buy |
49,921
+42,147
| +542% | +$1.52M | ﹤0.01% | 3820 |
|
|
2023
Q2 | $312K | Sell |
7,774
-1,578,969
| -100% | -$65.3M | ﹤0.01% | 4858 |
|
|
2023
Q1 | $64.8M | Buy |
1,586,743
+434,989
| +38% | +$17.3M | 0.04% | 536 |
|
|
2022
Q4 | $44.5M | Buy |
1,151,754
+683,680
| +146% | +$33.3M | 0.02% | 826 |
|
|
2022
Q3 | $24.9M | Buy |
468,074
+436,699
| +1,392% | +$24.3M | 0.01% | 1146 |
|
|
2022
Q2 | $1.83M | Buy |
+31,375
| New | +$2.06M | ﹤0.01% | 3792 |
|
|
2022
Q1 | – | Sell |
-132,483
| Closed | -$7.97M | – | 7331 |
|
|
2021
Q4 | $7.97M | Buy |
132,483
+63,661
| +93% | +$3.51M | ﹤0.01% | 2393 |
|
|
2021
Q3 | $3.85M | Sell |
68,822
-78,765
| -53% | -$4.54M | ﹤0.01% | 3176 |
|
|
2021
Q2 | $8.96M | Buy |
147,587
+33,247
| +29% | +$2.1M | 0.01% | 2049 |
|
|
2021
Q1 | $8.01M | Buy |
114,340
+28,356
| +33% | +$2.03M | 0.01% | 2037 |
|
|
2020
Q4 | $5.14M | Buy |
85,984
+1,995
| +2% | +$117K | ﹤0.01% | 2406 |
|
|
2020
Q3 | $5.05K | Buy |
83,989
+80,059
| +2,037% | +$4.65M | 0.01% | 1836 |
|
|
2020
Q2 | $206K | Sell |
3,930
-164,524
| -98% | -$6.88M | ﹤0.01% | 3836 |
|
|
2020
Q1 | $5.65M | Sell |
168,454
-118,226
| -41% | -$4.91M | 0.01% | 1245 |
|
|
2019
Q4 | $13M | Sell |
286,680
-352,459
| -55% | -$15M | 0.02% | 1162 |
|
|
2019
Q3 | $24.3M | Sell |
639,139
-844,598
| -57% | -$33.7M | 0.04% | 653 |
|
|
2019
Q2 | $64.5M | Buy |
1,483,737
+390,034
| +36% | +$16.6M | 0.1% | 236 |
|
|
2019
Q1 | $41.6M | Sell |
1,093,703
-130,811
| -11% | -$5.11M | 0.06% | 410 |
|
|
2018
Q4 | $52.7M | Sell |
1,224,514
-204,456
| -14% | -$9.54M | 0.08% | 323 |
|
|
2018
Q3 | $70.2M | Buy |
1,428,970
+376,467
| +36% | +$16.3M | 0.09% | 297 |
|
|
2018
Q2 | $33.7M | Buy |
1,052,503
+164,112
| +18% | +$5.67M | 0.04% | 597 |
|
|
2018
Q1 | $27.7M | Buy |
888,391
+348,542
| +65% | +$12.4M | 0.04% | 702 |
|
|
2017
Q4 | $24.6M | Buy |
+539,849
| New | +$21.4M | 0.03% | 769 |
|
|
2017
Q3 | – | Sell |
-731,065
| Closed | -$34.9M | – | 3774 |
|
|
2017
Q2 | $34.9M | Buy |
731,065
+593,742
| +432% | +$27.5M | 0.06% | 446 |
|
|
2017
Q1 | $6.26M | Sell |
137,323
-915,828
| -87% | -$39.6M | 0.01% | 1319 |
|
|
2016
Q4 | $34M | Buy |
1,053,151
+891,236
| +550% | +$29.7M | 0.07% | 388 |
|
|
2016
Q3 | $5.54M | Sell |
161,915
-619,691
| -79% | -$24.3M | 0.01% | 1277 |
|
|
2016
Q2 | $26.4M | Buy |
781,606
+338,206
| +76% | +$16.6M | 0.06% | 400 |
|
|
2016
Q1 | $23.5M | Buy |
443,400
+22,014
| +5% | +$1.29M | 0.06% | 418 |
|
|
2015
Q4 | $32.4M | Sell |
421,386
-89,713
| -18% | -$5.08M | 0.07% | 394 |
|
|
2015
Q3 | $21M | Sell |
511,099
-34,471
| -6% | -$2.11M | 0.04% | 552 |
|
|
2015
Q2 | $38.6M | Buy |
545,570
+465,661
| +583% | +$36.7M | 0.07% | 342 |
|
|
2015
Q1 | $7.1M | Sell |
79,909
-89,365
| -53% | -$9.07M | 0.01% | 1226 |
|
|
2014
Q4 | $15M | Buy |
169,274
+87,275
| +106% | +$8.26M | 0.03% | 748 |
|
|
2014
Q3 | $7.95M | Sell |
81,999
-259,178
| -76% | -$25.2M | 0.02% | 998 |
|
|
2014
Q2 | $31.3M | Buy |
341,177
+20,843
| +7% | +$1.59M | 0.09% | 277 |
|
|
2014
Q1 | $22.4M | Buy |
320,334
+246,708
| +335% | +$16.8M | 0.07% | 400 |
|
|
2013
Q4 | $4.23M | Sell |
73,626
-323,506
| -81% | -$17M | 0.01% | 1297 |
|
|
2013
Q3 | $19.1M | Sell |
397,132
-182,258
| -31% | -$6.64M | 0.06% | 369 |
|
|
2013
Q2 | $16.8M | Buy |
+579,390
| New | +$16.8M | 0.05% | 378 |
|
Other funds holding PCRX
DPCM
VPM
VCM
Millennium Management's PCRX Position: Q1 2026 in Review
Millennium Management reduced its Pacira BioSciences (PCRX) stake by 53% in Q1 2026, selling an estimated $1.46M and leaving 57,031 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4196.
Millennium Management first reported a position in PCRX in Q2 2013 and has held it in 48 quarters since. The position peaked at $70.2M in Q3 2018. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.
- Millennium Management held 57,031 shares of Pacira BioSciences worth $1.29M as of Q1 2026.
- Millennium Management sold 65,575 Pacira BioSciences shares in Q1 2026, an estimated $1.46M.
- Pacira BioSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4196 holding.
- Millennium Management first reported a position in Pacira BioSciences in Q2 2013 and has held it in 48 quarters since.
- Millennium Management's Pacira BioSciences position peaked at $70.2M in Q3 2018.
- 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.